Doctors doing clinical trials on Mesothelioma with contact information
St. Vincent Medical Center - Los Angeles, California
Charles Wiseman, MD, FACP, Protocol chair Ph: 213-483-8464
Roswell Park Cancer Institute, Buffalo, New Yor
Todd Demmy, MD, Protocol chair Ph: 716-845-5873; 800-685-6825
Eastern Cooperative Oncology Group
Nasser Hanna, MD, Protocol chair Ph: 317-274-3515; 888-600-4822
Corey Langer, MD, Protocol co-chair Ph: 215-728-2985; 888-369-2427
Email: cj_langer@fccc.edu
North Central Cancer Treatment Group
Scott Okuno, MD, Protocol chair Ph: 507-284-2511
Email: okuno.scott@mayo.edu
Southwest Oncology Group
Linda Garland, MD, Protocol chair Ph: 520-626-3434; 800-622-2673
Email: lgarland@azcc.arizona.edu
Antoinette Wozniak, MD, Protocol co-chair Ph: 313-576-8752; 800-527-6266
Email: wozniakt@karmanos.org
Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute
Massachusetts General Hospital Cancer Center, Boston, Massachusettes
University of Chicago Cancer Research Center
Joan Lucca, RN Ph: 617-632-5403
Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute
Geoffrey Shapiro, MD, PhD, Principal investigator Ph: 617-632-4942; 866-790-4500
Email: geoffrey_shapiro@dfci.harvard.edu
University of Chicago Cancer Research Center, Chicago, IL
Herbert Irving Comprehensive Cancer Center at Columbia University, NY, NY
Jonathan Dowell, MD Principal Investigator
Ph: 214-648-4180, Email: jonathan.dowell@utsouthwestern.edu
Erin Fenske Ph: 214-648-7097, Email: erin.fenske@utsouthwestern.edu
Case Comprehensive Cancer Center, Cleveland, Ohio
David Adelstein, MD, Protocol chair Ph: 216-444-9310
California Cancer Consortium
Suresh Ramalingam, MD, Protocol chair Ph: 412-648-6619
Email: ramalingams@upmc.edu
NCIC-Clinical Trials Group
Scott Laurie, MD, FRCPC, Protocol chair Ph: 613-533-6430
NCI - Center for Cancer Research
David Schrump, MD, Protocol chair Ph: 301-451-1233
Email: david_schrump@nih.gov
NCI - Center for Cancer Research
Raffit Hassan, MD, Principal investigator Ph: 301-451-8742
Memorial Sloan-Kettering Cancer Center, NY, NY
Lee Krug, MD, Principal investigator Ph: 212-639-8420; 800-525-2225
Abramson Cancer Center of the University of Pennsylvania
Biogen Idec, Incorporated
Daniel H. Sterman, M.D. Principal Investigator
Adri Recio, RN Ph: 215-573-6760
Merck and Company, Incorporated
Medical Monitor Study Director
Toll Free Number Ph: 1-888-577-8839
Bristol-Myers Squibb Company - New York
BMS Call Center Ph: 866-892-1BMS
Daiichi Pharmaceutical Corporation
Robert Gazak Ph: 919-465-4653
Alfacell Corporation
Diane Scudiery, Protocol chair Ph: 973-748-8082